Perrigo Co PLC (PRGO)

76.36
0.10 0.12
NYSE : Health Care
Prev Close 76.46
Open 75.77
Day Low/High 75.20 / 76.52
52 Wk Low/High 74.90 / 152.36
Volume 608.43K
Avg Volume 1.80M
Exchange NYSE
Shares Outstanding 143.37M
Market Cap 10.98B
P/E Ratio N/A
Div & Yield 0.58 (0.80%)

Latest News

Closing Bell: Volkswagen Secures Plea Deal; Trump Triggers Biotech Selloff

Closing Bell: Volkswagen Secures Plea Deal; Trump Triggers Biotech Selloff

Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July.

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different

CEO Joe Papa tried to distance the company from its past troubles at the annual J.P. Morgan Healthcare Conference.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

Cramer: Reviewing S&P's Hit-and-Miss Parade

Cramer: Reviewing S&P's Hit-and-Miss Parade

Even among the losers, buys are scarce.

Make Sure Your Portfolio Is Protected From Volatility

Make Sure Your Portfolio Is Protected From Volatility

If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.

Watch Beaten-Down Drug Companies, Hospitals in 2017

Watch Beaten-Down Drug Companies, Hospitals in 2017

There may be some diamonds-in-the-rough among pharmaceutical consolidators and hospital chains.

Allergan's a Bargain That Could Pop 20%

Allergan's a Bargain That Could Pop 20%

When it comes to Perrigo, many stubborn traders have been transformed into long-term investors.

Can't Anyone Make Up Their Mind?

There's a whole lot of flip-flopping in the market.

Ranking the Activists for Proxy Season 2016

Ranking the Activists for Proxy Season 2016

We recount the successes and failures of the biggest names in the activism game.

Analysts' Actions -- Disney, Nvidia, Perrigo, Archer-Daniels and More

Analysts' Actions -- Disney, Nvidia, Perrigo, Archer-Daniels and More

Here are Friday's top research calls, including upgrades for Nvidia and Perrigo, a downgrade for Archer-Daniels and mixed reactions to Disney's most recent earnings results.

Perrigo Company Becomes #244 Most Shorted S&P 500 Component, Replacing Noble Energy

Perrigo Company Becomes #244 Most Shorted S&P 500 Component, Replacing Noble Energy

The most recent short interest data has been released for the 10/31/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition

Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition

Perrigo takes a third-quarter writedown of $1.67 billion on its Belgian purchase of two years ago, and will take the private equity firm and Omega's founder to arbitration court.

Valeant Shares Are Destroyed After Disastrous Third Quarter

Valeant Shares Are Destroyed After Disastrous Third Quarter

The troubled drugmaker's new CFO hinted that 2017 top- and bottom-line figures would be lower than 2016 levels.

Stressed Out: Valeant Shareholders Flee on McKesson Warning

Stressed Out: Valeant Shareholders Flee on McKesson Warning

The drugmaker's shares were hammered Friday on news that the industry is slashing prices.

Starboard DepoMed Director Deal Bolsters Sale Prospects

Starboard DepoMed Director Deal Bolsters Sale Prospects

The pain medication maker struck a deal with the fund managed by insurgent Jeff Smith to install a minority-slate of three dissident directors onto its board.

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

With a $31 billion debt load, the drugmaker has to show it has the firepower needed to fend off creditors.

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

With a $31 billion debt load, the drugmaker has to show it has the firepower needed to fend off creditors.

Is This Octoberfest? No, It's Chopfest

Statistically, today was not a good day.